Fempulse Corporation
Clinical trials sponsored by Fempulse Corporation, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New wearable zaps bladder woes without surgery Results expected May 2027 (estimated)
-
New Non-Implanted device aims to ease overactive bladder woes
Symptom relief CompletedThis study tested whether women with overactive bladder (OAB) could easily use the FemPulse System, a non-implanted vaginal electrical stimulation device. Eleven women with OAB symptoms used the device and completed a survey about its usability. The goal was simply to see if the …
Sponsor: FemPulse Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New wearable device could zap overactive bladder symptoms without surgery
Symptom relief CompletedThis completed trial tested a new non-implanted device that uses mild electrical stimulation to help control overactive bladder in women. 21 women with the condition used the FemPulse System, and researchers tracked side effects, urinary frequency, urgency, and quality of life. T…
Sponsor: FemPulse Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New device for overactive bladder passes usability test
Symptom relief CompletedThis study tested whether women with overactive bladder (OAB) can easily use the FemPulse system at home. Five women with OAB for over 6 months participated. The main goal was to see if they were satisfied with using the device as instructed.
Sponsor: FemPulse Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC